24 septembre 2025|
AI
|2 months agoUS Tariffs Force Swiss Economic Rethink
Switzerland faces unprecedented 39% US tariffs, prompting urgent trade diversification efforts and concerns in pharmaceutical sector
AI
Generated IllustrationKey Takeaways
AI
- The United States has imposed a 39% tariff rate on Swiss goods.
- Talks between the Swiss pharmaceutical industry and the government failed to produce a solution regarding US customs policy.
- US President Donald Trump set a deadline of the end of September 2025 for the Swiss pharma industry to lower export prices.
- Switzerland is accelerating trade agreement talks with India, Mercosur, and Thailand.
- 18% of Swiss exports currently go to the United States.
By The Numbers
39%
Tariff Rate
18%
Export Share
They Said
"We have agreed to continue this discussion rapidly and to repeat the exercise at a later date."
"Switzerland is indeed pushing harder than ever to diversify its trade."
1
Economic Shockwave: The 39% Tariff Reality
2
Pharma Deadlock: The Clock Ticks Down
3
The Great Pivot: Scrambling for New Allies
4